Effect on bone anabolic markers of daily cheese intake with and without vitamin K 2: A randomised clinical trial

2Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Background Daily intake of 57 g Jarlsberg cheese has been shown to increase the total serum osteocalcin (tOC). Is this a general cheese effect or specific for Jarlsberg containing vitamin K 2 and 1,4-dihydroxy-2naphtoic acid (DHNA)? Methods 66 healthy female volunteers (HV) were recruited. By skewed randomisation (3:2), 41 HV were allocated to daily intake of 57 g Jarlsberg (J-group) and 25-50 g Camembert (C-group) in 6 weeks. After 6 weeks the C-group was switched to Jarlsberg. The study duration was 12 weeks with clinical investigations every 6 weeks. The main variables were procollagen type 1 N-terminal propeptide (PINP), tOC, carboxylated osteocalcin (cOC) and the osteocalcin ratio (R O) defined as the ratio between cOC and undercarboxylated osteocalcin (ucOC). Serum cross-linked C-telopeptide type I collagen (CTX), vitamin K 2, lipids and clinical chemistry were used as secondary variables. Results PINP, tOC, cOC, R O and vitamin K 2 increased significantly (p<0.01) after 6 weeks in the J-group. PINP remained unchanged in the C-group. The other variables decreased slightly in the C-group but increased significantly (p≤0.05) after switching to Jarlsberg. No CTX-changes detected in neither of the groups. Serum lipids increased slightly in both groups. Switching to Jarlsberg, total cholesterol and low-density lipoprotein-cholesterol were significantly reduced (p≤0.05). Glycated haemoglobin (HbA1c), Ca ++ and Mg ++ were significantly reduced in the J-group, but unchanged in the C-group. Switching to Jarlsberg, HbA1c and Ca ++ decreased significantly. Conclusion The effect of daily Jarlsberg intake on increased s-osteocalcin level is not a general cheese effect. Jarlsberg contain vitamin K 2 and DHNA which increases PINP, tOC, cOC and R O and decreases Ca ++, Mg ++ and HbA1c. These effects reflect increased bone anabolism and a possible reduced risk of adverse metabolic outcomes. Trial registration number NCT04189796.

Cite

CITATION STYLE

APA

Lundberg, H. E., Glasø, M., Chhura, R., Shukla, A. A., Austlid, T., Sarwar, Z., … Larsen, S. E. (2022). Effect on bone anabolic markers of daily cheese intake with and without vitamin K 2: A randomised clinical trial. BMJ Nutrition, Prevention and Health, 5(2), 182–190. https://doi.org/10.1136/bmjnph-2022-000424

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free